Generic drug manufacturers are constantly challenging positions of innovator patents. Best practices for innovator pharmaceutical companies is to identify and patent or publish all relevant API phases, including co-crystals. Crystal Pharmatech offers the most advanced and thorough screening techniques to identify and understand the entire API phase landscape. We also have years of experience in patenting API phases. Since our research team has worked for innovator companies for many years, we have unparalleled experience in designing bullet proof applications and providing expert witness testimony. Additionally, we have the most advanced techniques to unambiguously identify when patents are being infringed.
Consultancy and Training 
